SANA Valuation

Sana Biotechnology Inc

Add to Watchlist

Advanced Chart

4.950

-0.18(-3.509%)1D

Overview
Forecast
Valuation
Earnings

SANA Relative Valuation

SANA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SANA is overvalued; if below, it's undervalued.

Historical Valuation

Sana Biotechnology Inc (SANA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -5.14. The fair price of Sana Biotechnology Inc (SANA) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：4.78

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

5.53

P/B

Median3y

2.76

Median5y

2.80

-19.31

FCF Yield

Median3y

-33.93

Median5y

-26.72

Competitors Valuation Multiple

The average P/S ratio for SANA's competitors is 9.37, providing a benchmark for relative valuation. Sana Biotechnology Inc Corp (SANA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SANA.O

Sana Biotechnology Inc

Loss

Average P/S: 9.37

1.12B